-
Mashup Score: 1Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - 2 year(s) ago
The burden of diabetes in the Americas is large, increasing, heterogeneous, and expanding. To confront the rising burden, population-based interventions aimed to reduce type 2 diabetes risk and strengthening health systems to provide effective and cost-efficient care for those affected are mandatory.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0The Lancet Diabetes & Endocrinology, September 2022, Volume 10, Issue 9, Pages 609-680, e9 - 2 year(s) ago
Explore the current issue of The Lancet Diabetes & Endocrinology, a monthly journal focussed on diabetes, endocrinology, and metabolism
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 7Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - 2 year(s) ago
The burden of diabetes in the Americas is large, increasing, heterogeneous, and expanding. To confront the rising burden, population-based interventions aimed to reduce type 2 diabetes risk and strengthening health systems to provide effective and cost-efficient care for those affected are mandatory.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - 2 year(s) ago
The burden of diabetes in the Americas is large, increasing, heterogeneous, and expanding. To confront the rising burden, population-based interventions aimed to reduce type 2 diabetes risk and strengthening health systems to provide effective and cost-efficient care for those affected are mandatory.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 12
The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - 2 year(s) ago
The burden of diabetes in the Americas is large, increasing, heterogeneous, and expanding. To confront the rising burden, population-based interventions aimed to reduce type 2 diabetes risk and strengthening health systems to provide effective and cost-efficient care for those affected are mandatory.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 7
The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Blood glucose targets in the critically ill: is one size fits all still appropriate? - 2 year(s) ago
In 2001, the paradigm for blood glucose control in hospitalised patients was challenged by a single-centre, randomised controlled trial (RCT).1 Conducted in mechanically ventilated surgical intensive care unit (ICU) patients (970 [63%] of 1548 following cardiovascular surgery and 1344 [87%] without a previous diagnosis of diabetes), this trial used intravenous insulin to target euglycaemia (blood…
Categories: Endocrinology, Latest HeadlinesTweet
In the September Issue: Burden of #diabetes and #hyperglycaemia in adults in the #Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 https://t.co/dZDOJfSRtH #OpenAccess https://t.co/wzeYLpDq4a